3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
38
Neoplasms
33
Depression
28
Fatigue
24
Prostatic Neoplasms
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
18
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Follicular
17
Multiple Myeloma
15
Lymphoma, Non-Hodgkin
14
Lymphoma, Mantle-Cell
14
Leukemia, Lymphocytic, Chronic, B-Cell
14
Burkitt Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
13
Leukemia, Myeloid, Acute
13
Hodgkin Disease
13
Colorectal Neoplasms
13
Lymphoma, Large-Cell, Immunoblastic
12
Lung Neoplasms
12
Anxiety Disorders
12
Lymphoma
11
Leukemia, Myeloid, Chronic-Phase
11
Blast Crisis
11
Leukemia, Myeloid, Accelerated Phase
10
Recurrence
9
Pain
9
Lymphoma, T-Cell, Cutaneous
9
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
9
Leukemia, Hairy Cell
9
Leukemia
9
Interventions
Metformin
139
Clomiphene
44
Letrozole
36
Inositol
28
Folic Acid
17
Exercise
17
Progesterone
16
Ethinyl Estradiol
13
Caloric Restriction
13
drospirenone and ethinyl estradiol combination
12
Estradiol
12
Contraceptives, Oral
11
cetrorelix
10
Pioglitazone
10
High-Intensity Interval Training
10
Chorionic Gonadotropin
10
Triptorelin Pamoate
9
Tablets
9
Spironolactone
8
Diet
8
Cholecalciferol
8
Vitamin D
7
Thioctic Acid
7
Surveys and Questionnaires
7
Menotropins
7
Liraglutide
7
Gonadotropins
7
Acupuncture Therapy
7
drospirenone
6
Ovidrel
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Polycystic Ovary Syndrome
×
Therapeutics
×
Clear all
NCT00378729
2011-10-04
PERCING
Assistance Publique - Hôpitaux de Paris
Phase 4
Unknown
252 enrolled